Jeffrey Freitag, M.D., senior vice president, PharmaNet Consulting, will also become chief medical officer of PharmaNet Development Group, Inc. Dr. Freitag will be the senior medical representative for the company and provide guidance to physicians involved in designing and monitoring Phase I – Phase III trials. He will also continue to head PharmaNet’s team of regulatory and pharmaceutical consultants.

“Excellence in pharmaceutical science and medicine is critical to the success of PharmaNet and its clients. We are therefore very pleased that Dr. Jeffrey Freitag, an accomplished internist and nephrologist, will be serving in the role of CMO,” said Dr. Tom Newman, president of PharmaNet Development Group.

Dr. Freitag has worked in the pharmaceutical industry for more than 25 years in a variety of positions including vice president, clinical drug development at The Liposome Co., senior vice president of Medical Affairs at PharmaNet and most recently as vice president of R&D at Bone Care International before rejoining PharmaNet in 2006.